Iraq vs Kiribati: Cause of death, by non-communicable diseases, ages 60+, male
Iraq
79.6%
in 2021
Kiribati
80.2%
in 2021
Iraq rank
44th
Kiribati rank
42nd
Cause of death, by non-communicable diseases, ages 60+, male over time
- Iraq
- Kiribati
How they compare
Kiribati currently reports 80.2% against 79.6% in Iraq, a difference of 0.6%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Iraq ahead.
Iraq ranks 44th and Kiribati ranks 42nd of 185 countries.
Across the 3 decades both report, Iraq averaged higher in 2 and Kiribati in 1.
Head to head by decade
| Decade | Iraq | Kiribati | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 91.8% | 82.8% | 9.0% | Iraq |
| 2010s | 91.9% | 85.3% | 6.6% | Iraq |
| 2020s | 78.5% | 82.3% | 3.8% | Kiribati |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, male, Iraq or Kiribati?
- Kiribati, at 80.2% against 79.6% in Iraq as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+, male between Iraq and Kiribati?
- 0.6%, with Kiribati ahead.
- How many years of comparable data are there for Iraq and Kiribati?
- 6 years are reported by both, from 2000 to 2021.
- How do Iraq and Kiribati rank globally for cause of death, by non-communicable diseases, ages 60+, male?
- Iraq ranks 44th and Kiribati ranks 42nd of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, male (% of total male deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 60+ due to non-communicable diseases divided by number of all male deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.